Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 21, 2014; 20(39): 14237-14245
Published online Oct 21, 2014. doi: 10.3748/wjg.v20.i39.14237
Published online Oct 21, 2014. doi: 10.3748/wjg.v20.i39.14237
Year | n | Type study | Mean age (yr) | ChemotherapyAgents regimen | RadiotherapyDose (Gy) IORT | |||||
Gillen et al[2] | 80-09 | 111 | 78P-33R | 62.5 | 107 (96.4) | 5FU > GEM > Tax > Others | 44S + 48C | 104 (93.7) | 24-63 | 13 (12.5) |
Assifi et al[35] | 93-10 | 14 | 14P-0R | N/P | 14 (100) | GEM > 5FU | 3S + 11C | 12 (85) | 30-50 | 0 (0) |
Andriulli et al[36] | 97-08 | 20 | 20P-0R | 63.0 | 20 (100) | GEM > Cis | 13S + 7C | 17 (85) | 30-40 | N/P |
- Citation: Álamo JM, Marín LM, Suarez G, Bernal C, Serrano J, Barrera L, Gómez MA, Muntané J, Padillo FJ. Improving outcomes in pancreatic cancer: Key points in perioperative management. World J Gastroenterol 2014; 20(39): 14237-14245
- URL: https://www.wjgnet.com/1007-9327/full/v20/i39/14237.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i39.14237